# Phase I Human Analytics (HALO) Study

> **NCT05423860** · — · RECRUITING · sponsor: **HALO Diagnostics** · enrollment: 2000 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Cancer
- Dementia
- Traumatic Brain Injury

## Interventions

- **OTHER:** no interventions will be performed (observational)

## Key facts

- **NCT ID:** NCT05423860
- **Lead sponsor:** HALO Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-16
- **Primary completion:** 2027-03
- **Final completion:** 2037-03
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2022-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05423860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05423860, "Phase I Human Analytics (HALO) Study". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05423860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*